BioCryst Pharmaceuticals, Inc. (BCRX)
8.52
-0.05
(-0.58%)
USD |
NASDAQ |
Sep 24, 16:00
8.515
0.00 (0.00%)
After-Hours: 19:59
BioCryst Pharmaceuticals Gross Profit (Annual) : 854.37M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 854.37M |
| December 31, 2024 | 436.98M |
| December 31, 2023 | 325.10M |
| December 31, 2022 | 262.80M |
| December 31, 2021 | 149.13M |
| December 31, 2020 | 16.14M |
| December 31, 2019 | 44.73M |
| December 31, 2018 | 19.80M |
| December 31, 2017 | 23.48M |
| December 31, 2016 | 23.65M |
| December 31, 2015 | 46.36M |
| December 31, 2014 | 13.40M |
| December 31, 2013 | 16.93M |
| December 31, 2012 | 25.53M |
| December 31, 2011 | 18.76M |
| December 31, 2010 | 60.03M |
| Date | Value |
|---|---|
| December 31, 2009 | 70.05M |
| December 31, 2008 | 54.94M |
| December 31, 2007 | 69.87M |
| December 31, 2006 | 5.391M |
| December 31, 2005 | -0.7127M |
| December 31, 2004 | -0.6325M |
| December 31, 2003 | 0.00 |
| December 31, 2002 | 0.00 |
| December 31, 2001 | 0.00 |
| December 31, 2000 | 0.00 |
| December 31, 1999 | 0.00 |
| December 31, 1998 | 0.00 |
| December 31, 1997 | 0.00 |
| December 31, 1996 | 0.00 |
| December 31, 1995 | 0.00 |
| December 31, 1994 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Amgen, Inc. | 26.01B |
| Halozyme Therapeutics, Inc. | 1.091B |
| Neurocrine Biosciences, Inc. | 2.808B |
| Vertex Pharmaceuticals, Inc. | 10.27B |
| Agenus, Inc. | 103.18M |